OPRK1 and hepatocellular carcinoma: Taken together, malignant phenotypes of HCC cells including cell proliferation, colony formation and migration can be suppressed by KOR activation either via the KOR-specific agonist U50488h or via the mixed agonist oxycodone, but not by MOR activation via the MOR-specific agonist morphine.